首页 > 最新文献

Lancet Public Health最新文献

英文 中文
Natural history of alcohol-use disorders: not the end of the story 酒精使用障碍的自然历史:故事还没有结束
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-28 DOI: 10.1016/s2468-2667(25)00255-5
Tim Slade, Siobhan O'Dean
{"title":"Natural history of alcohol-use disorders: not the end of the story","authors":"Tim Slade, Siobhan O'Dean","doi":"10.1016/s2468-2667(25)00255-5","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00255-5","url":null,"abstract":"","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"4 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145382794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between exposure to digital alcohol marketing and alcohol use: a systematic review and meta-analysis 接触数字酒精营销与饮酒之间的关系:系统回顾和荟萃分析
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-28 DOI: 10.1016/s2468-2667(25)00219-1
Scott I Donaldson, Alex M Russell, Kathryn La Capria, Amanda DeJesus, Emily Wang, Jamil Fayad, Jon-Patrick Allem
{"title":"Association between exposure to digital alcohol marketing and alcohol use: a systematic review and meta-analysis","authors":"Scott I Donaldson, Alex M Russell, Kathryn La Capria, Amanda DeJesus, Emily Wang, Jamil Fayad, Jon-Patrick Allem","doi":"10.1016/s2468-2667(25)00219-1","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00219-1","url":null,"abstract":"","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"25 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145382798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Poverty and death in the wealthiest of nations 最富裕国家的贫穷和死亡
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-28 DOI: 10.1016/s2468-2667(25)00252-x
David U Himmelstein, Steffie Woolhandler
{"title":"Poverty and death in the wealthiest of nations","authors":"David U Himmelstein, Steffie Woolhandler","doi":"10.1016/s2468-2667(25)00252-x","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00252-x","url":null,"abstract":"","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"60 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145382801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The natural history of DSM-5 alcohol-use disorder from late adolescence to middle adulthood in Australia: a prospective cohort study DSM-5酒精使用障碍从青春期晚期到成年中期的自然历史:一项前瞻性队列研究
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-28 DOI: 10.1016/s2468-2667(25)00225-7
Jessica A Kerr, Hanafi Mohamad Husin, Janni Leung, S Ghazaleh Dashti, Louisa Degenhardt, Susan Ellul, Elizabeth A Spry, Susan M Sawyer, Gabrielle Campbell, Wayne D Hall, Tesfa Mekonen Yimer, Gary Chung Kai Chan, George C Patton, Craig A Olsson
{"title":"The natural history of DSM-5 alcohol-use disorder from late adolescence to middle adulthood in Australia: a prospective cohort study","authors":"Jessica A Kerr, Hanafi Mohamad Husin, Janni Leung, S Ghazaleh Dashti, Louisa Degenhardt, Susan Ellul, Elizabeth A Spry, Susan M Sawyer, Gabrielle Campbell, Wayne D Hall, Tesfa Mekonen Yimer, Gary Chung Kai Chan, George C Patton, Craig A Olsson","doi":"10.1016/s2468-2667(25)00225-7","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00225-7","url":null,"abstract":"","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"115 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145382808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unsecured debt in early adulthood and premature mortality in adults in the USA: a longitudinal analysis of prospective national cohort data 美国成人早期无担保债务和过早死亡:前瞻性国家队列数据的纵向分析
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-28 DOI: 10.1016/s2468-2667(25)00226-9
Samuel L Swift, Zihan Chen, Calvin Colvin, Katrina Kezios, Sebastian Calonico, Adina Zeki Al Hazzouri
{"title":"Unsecured debt in early adulthood and premature mortality in adults in the USA: a longitudinal analysis of prospective national cohort data","authors":"Samuel L Swift, Zihan Chen, Calvin Colvin, Katrina Kezios, Sebastian Calonico, Adina Zeki Al Hazzouri","doi":"10.1016/s2468-2667(25)00226-9","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00226-9","url":null,"abstract":"","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"1 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145382813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A public health perspective on assisted dying and its different modalities 从公共卫生角度看协助死亡及其不同方式
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-28 DOI: 10.1016/s2468-2667(25)00245-2
Paola Sillitti, Clément Meier, Solenne Blanc, Laura Jones, Claudia Gamondi
{"title":"A public health perspective on assisted dying and its different modalities","authors":"Paola Sillitti, Clément Meier, Solenne Blanc, Laura Jones, Claudia Gamondi","doi":"10.1016/s2468-2667(25)00245-2","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00245-2","url":null,"abstract":"","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"101 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145383803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mental health: a public health crisis unfolding 精神卫生:一场正在展开的公共卫生危机
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-27 DOI: 10.1016/s2468-2667(25)00261-0
More than 1 billion people worldwide live with a mental health condition. One in seven young people. Despite these alarming numbers, the public health response is woefully inadequate. In the words of Dr Tedros, WHO Director General, “Mental health remains one of the most neglected areas of public health and health services delivery”. Indeed, the WHO report World Mental Health Today, published in September, paints a sobering picture with rising incidence rates, persistent service gaps, and a glaring neglect of youth-specific mental health needs. The global prevalence of mental health disorders reached 13·6%; 0·9% higher than a decade ago. The 2023 Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) published on Oct 12 reported a staggering increase in the burden of mental disorders globally. The leading mental health burdens are depression and anxiety, with the peak now occurring in those aged 15–19 years—an increase driven mainly by depressive and anxiety disorders. Since 2010, anxiety disorders in this age group have risen by nearly 70%, and depression by about 30%. This trajectory should be a cause for concern.
全世界有超过10亿人患有精神疾病。七分之一的年轻人。尽管这些数字令人震惊,但公共卫生应对措施严重不足。用世卫组织总干事谭德塞博士的话来说,“精神卫生仍然是公共卫生和卫生服务提供中最被忽视的领域之一”。事实上,世卫组织9月发表的《今日世界精神卫生》报告描绘了一幅令人警醒的画面:发病率不断上升,服务差距持续存在,对青年特定精神卫生需求的明显忽视。全球精神卫生障碍患病率达到13.6%;比十年前高出0.9%。10月12日发布的《2023年全球疾病、伤害和风险因素负担研究》(GBD)报告称,全球精神障碍负担出现了惊人的增长。主要的心理健康负担是抑郁和焦虑,目前在15-19岁的人群中达到高峰,这主要是由抑郁和焦虑障碍造成的。自2010年以来,这一年龄段的焦虑症患者增加了近70%,抑郁症患者增加了约30%。这种轨迹应该引起关注。
{"title":"Mental health: a public health crisis unfolding","authors":"","doi":"10.1016/s2468-2667(25)00261-0","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00261-0","url":null,"abstract":"More than 1 billion people worldwide live with a mental health condition. One in seven young people. Despite these alarming numbers, the public health response is woefully inadequate. In the words of Dr Tedros, WHO Director General, “Mental health remains one of the most neglected areas of public health and health services delivery”. Indeed, the <span><span>WHO report</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span> <em>World Mental Health Today</em>, published in September, paints a sobering picture with rising incidence rates, persistent service gaps, and a glaring neglect of youth-specific mental health needs. The global prevalence of mental health disorders reached 13·6%; 0·9% higher than a decade ago. The 2023 Global Burden of Diseases, Injuries, and Risk Factors Study (<span><span>GBD</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>) published on Oct 12 reported a staggering increase in the burden of mental disorders globally. The leading mental health burdens are depression and anxiety, with the peak now occurring in those aged 15–19 years—an increase driven mainly by depressive and anxiety disorders. Since 2010, anxiety disorders in this age group have risen by nearly 70%, and depression by about 30%. This trajectory should be a cause for concern.","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"19 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145396686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050 1990-2021年世卫组织东地中海区域细菌抗微生物药物耐药性负担:一项到2050年预测的跨国系统分析
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-10-10 DOI: 10.1016/s2468-2667(25)00201-4
<h3>Background</h3>Antimicrobial resistance (AMR) is an urgent global crisis and one of the world's most complex challenges. Although there is increasing evidence of its impact on human mortality and morbidity, precise burden estimation has many challenges, and thus far has been elusive for the Eastern Mediterranean Region. Here, we present a comprehensive time-trend analysis of regional and country-level AMR burden estimates in the WHO Eastern Mediterranean Region (EMR), between 1990 and 2021, with forecasts up to 2050.<h3>Methods</h3>We estimated deaths and disability-adjusted life-years (DALYs) attributable to and associated with AMR for 11 infectious syndromes, 22 bacterial pathogens, and 84 pathogen–drug combinations for the WHO EMR and each of its countries from 1990 to 2021. Data were obtained from mortality registries, surveillance systems, hospital records, systematic literature reviews, and other sources. We based our modelling approach on five broad components: the number of deaths in which infection had a role, the proportion of infectious deaths attributable to a given infectious syndrome, the proportion of infectious syndrome deaths attributable to a given pathogen, the percentage of a given pathogen resistant to an antimicrobial drug of interest, and the excess risk of mortality (or duration of an infection) associated with this resistance. These components were then used to estimate the disease burden by using two counterfactual scenarios: deaths and DALYs attributable to AMR (considering an alternative scenario where drug-resistant infections are replaced with susceptible infections), and deaths and DALYs associated with AMR (considering an alternative scenario where infections would not occur at all). Predictive statistical modelling was applied to generate estimates of AMR burden for each country. We also generated AMR burden forecasts up to 2050. We generated 95% uncertainty intervals (UIs) for the final estimates by taking the 2·5th and 97·5th percentiles across 500 draws through the multistage computational pipeline, and models were cross-validated for out-of-sample predictive validity.<h3>Findings</h3>We estimated 380 000 deaths (95% UI 332 000–426 000) associated with bacterial AMR and 92 800 deaths (78 300–111 000) attributable to bacterial AMR in the EMR in 2021. In the past 31 years, there was considerable variation in AMR mortality trends across countries of the region and different age groups. Between 1990 and 2021, associated deaths among children younger than 5 years decreased by 50·0% (38·2–62·0), while those among adults aged 70 and older rose by over 85·7% (95% UI 57·0–115·7). Six pathogens were identified as the primary generators of burden: <em>Streptococcus pneumoniae, Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus, Acinetobacter baumannii</em>, and <em>Pseudomonas aeruginosa</em>. A substantial increase in the AMR burden due to <em>S aureus</em> was observed between 1990 (28 200 deaths [21 600
抗生素耐药性(AMR)是一个紧迫的全球危机,也是世界上最复杂的挑战之一。虽然有越来越多的证据表明它对人类死亡率和发病率的影响,但精确的负担估计有许多挑战,迄今为止东地中海区域一直难以做到这一点。在此,我们对世卫组织东地中海区域(EMR) 1990年至2021年期间的区域和国家一级抗菌素耐药性负担估计数进行了全面的时间趋势分析,并预测到2050年。方法:我们估计了1990年至2021年WHO EMR及其每个国家11种感染综合征、22种细菌性病原体和84种病原体-药物组合中与AMR相关的死亡和伤残调整生命年(DALYs)。数据来自死亡登记、监测系统、医院记录、系统文献综述和其他来源。我们的建模方法基于五个广泛的组成部分:感染造成的死亡人数、归因于特定感染综合征的感染死亡比例、归因于特定病原体的感染综合征死亡比例、对感兴趣的抗菌药物具有耐药性的特定病原体的百分比,以及与这种耐药性相关的过量死亡风险(或感染持续时间)。然后使用这些组成部分通过使用两种反事实情景来估计疾病负担:抗菌素耐药性导致的死亡和DALYs(考虑到耐药感染被易感感染取代的替代情景),以及与抗菌素耐药性相关的死亡和DALYs(考虑到根本不会发生感染的替代情景)。采用预测统计模型对每个国家的抗菌素耐药性负担进行估算。我们还预测了到2050年的抗菌素耐药性负担。通过多级计算管道,我们在500次抽取中取2.5%和97.5%的百分位数,为最终估计生成了95%的不确定性区间(ui),并对模型进行了样本外预测有效性的交叉验证。研究结果:我们估计,2021年EMR中有38万例死亡(95% UI为332000 - 426000)与细菌AMR相关,92 800例死亡(78 300 - 111000)归因于细菌AMR。在过去31年中,该区域各国和不同年龄组的抗菌素耐药性死亡率趋势存在相当大的差异。1990年至2021年期间,5岁以下儿童的相关死亡率下降了50.0%(38.2 - 60.2),而70岁及以上成年人的相关死亡率上升了85.7%以上(95% UI为57.0 - 11.7)。确定了六种主要病原体:肺炎链球菌、肺炎克雷伯菌、大肠埃希菌、金黄色葡萄球菌、鲍曼不动杆菌和铜绿假单胞菌。在1990年(28 200例死亡[21 600-34 000例])和2021年(49 500例死亡[43 100-56 200例])期间,观察到金黄色葡萄球菌造成的抗菌素耐药性负担大幅增加;因此,在2021年,耐甲氧西林金黄色葡萄球菌是该区域大多数国家可归因于并与抗菌素耐药性相关的死亡和伤残赔偿金的主要病原体-药物组合。索马里是该区域年龄标准化死亡率最高的国家:1990年和2021年,每10万人中因抗微生物药物耐药性导致和与之相关的死亡人数;相反,EMR负担最低的国家是卡塔尔。到2050年,该区域因抗菌素耐药性导致的死亡人数预计将达到18.7万(15.7万至22.3万),与抗菌素耐药性相关的死亡人数预计将达到752万(62.9万至87.9万)。我们的研究表明,30多年来,细菌AMR一直是EMR中一个严重的公共卫生威胁,对重点细菌病原体和病原体-药物组合具有重大的致命和非致命负担。这一问题的严重性、未来的项目以及许多国家应对能力不足,都突出表明需要在这一领域建立更严格的区域领导。从这项研究中获得的见解可以指导本区域内个别国家的有针对性的缓解战略,有助于资源分配和供资决策,并强调需要各国之间开展多部门合作,努力解决这一问题。使用弗莱明基金管理的援助资金资助威康信托基金和英国卫生和社会保障部。
{"title":"The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990–2021: a cross-country systematic analysis with forecasts to 2050","authors":"","doi":"10.1016/s2468-2667(25)00201-4","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00201-4","url":null,"abstract":"&lt;h3&gt;Background&lt;/h3&gt;Antimicrobial resistance (AMR) is an urgent global crisis and one of the world's most complex challenges. Although there is increasing evidence of its impact on human mortality and morbidity, precise burden estimation has many challenges, and thus far has been elusive for the Eastern Mediterranean Region. Here, we present a comprehensive time-trend analysis of regional and country-level AMR burden estimates in the WHO Eastern Mediterranean Region (EMR), between 1990 and 2021, with forecasts up to 2050.&lt;h3&gt;Methods&lt;/h3&gt;We estimated deaths and disability-adjusted life-years (DALYs) attributable to and associated with AMR for 11 infectious syndromes, 22 bacterial pathogens, and 84 pathogen–drug combinations for the WHO EMR and each of its countries from 1990 to 2021. Data were obtained from mortality registries, surveillance systems, hospital records, systematic literature reviews, and other sources. We based our modelling approach on five broad components: the number of deaths in which infection had a role, the proportion of infectious deaths attributable to a given infectious syndrome, the proportion of infectious syndrome deaths attributable to a given pathogen, the percentage of a given pathogen resistant to an antimicrobial drug of interest, and the excess risk of mortality (or duration of an infection) associated with this resistance. These components were then used to estimate the disease burden by using two counterfactual scenarios: deaths and DALYs attributable to AMR (considering an alternative scenario where drug-resistant infections are replaced with susceptible infections), and deaths and DALYs associated with AMR (considering an alternative scenario where infections would not occur at all). Predictive statistical modelling was applied to generate estimates of AMR burden for each country. We also generated AMR burden forecasts up to 2050. We generated 95% uncertainty intervals (UIs) for the final estimates by taking the 2·5th and 97·5th percentiles across 500 draws through the multistage computational pipeline, and models were cross-validated for out-of-sample predictive validity.&lt;h3&gt;Findings&lt;/h3&gt;We estimated 380 000 deaths (95% UI 332 000–426 000) associated with bacterial AMR and 92 800 deaths (78 300–111 000) attributable to bacterial AMR in the EMR in 2021. In the past 31 years, there was considerable variation in AMR mortality trends across countries of the region and different age groups. Between 1990 and 2021, associated deaths among children younger than 5 years decreased by 50·0% (38·2–62·0), while those among adults aged 70 and older rose by over 85·7% (95% UI 57·0–115·7). Six pathogens were identified as the primary generators of burden: &lt;em&gt;Streptococcus pneumoniae, Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus, Acinetobacter baumannii&lt;/em&gt;, and &lt;em&gt;Pseudomonas aeruginosa&lt;/em&gt;. A substantial increase in the AMR burden due to &lt;em&gt;S aureus&lt;/em&gt; was observed between 1990 (28 200 deaths [21 600","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"38 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145260714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National roll-out of social prescribing in England's primary care system: a longitudinal observational study using Clinical Practice Research Datalink data 英国初级保健系统中社会处方的全国推广:使用临床实践研究数据链数据的纵向观察研究
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-09-26 DOI: 10.1016/s2468-2667(25)00217-8
Feifei Bu, Alexandra Burton, Naomi Launders, Amy E Taylor, Alvin Richards-Belle, Stephanie Tierney, David Osborn, Daisy Fancourt

Background

Social prescribing is growing rapidly in England and across the world. However, it remains unclear who it is reaching and how effectively it is being implemented. This study aimed to assess longitudinal trends in social prescribing in England's primary care system, including growth trajectories and target alignment, sociodemographic profiles of referred patients, and predictors of service refusal over time.

Methods

This nationwide, longitudinal observational study analysed primary care records from 1·2 million patients from 1736 general practitioner (GP) practices in the Clinical Practice Research Datalink in England. We estimated social prescribing trends between 2019 and 2023 using growth curve modelling on social prescribing numbers at the practice level. Descriptive analyses were used to show changes in sociodemographic profiles of social prescribing patients over time. To assess sociodemographic disparities in service refusal (defined as having a medical code of social prescribing declined), we used multilevel logistic regression models stratified by year, accounting for nested data structure where patients were nested within practices.

Findings

As of the end of 2023, an estimated 9·4 million GP consultations in England have involved social prescribing codes, and 5·5 million consultations have specifically led to social prescribing referrals. In 2023 alone, an estimated 1·3 million patients were referred to social prescribing. 60% of patients offered social prescribing were female and 23% were from ethnic minority groups. Representation from patients living in more deprived areas increased from 23% to 42% between 2017 and 2023. Service refusal declined from 22% to 12% between 2019 and 2023. Age, sex, and ethnicity were associated with service refusal across multiple years. Notably, in 2023, all age groups had higher odds of refusal compared with the youngest age group. Female patients had 21% (95% CI 0·77–0·82) lower odds of refusal than males, and patients from White ethnic backgrounds had 32% (1·26–1·39) higher odds of refusal than ethnic minority patients.

Interpretation

Social prescribing has expanded rapidly in England, far exceeding initial targets of 900 000 patients by 2023–24, suggesting broad service acceptability. Progress is being made in reaching specific target groups, such as more deprived communities. However, there are still disparities in accessibility and uptake, calling for targeted strategies to address underlying inequalities.

Funding

MQ Transforming Mental Health, Rosetrees-Stoneygate Trust Fellowship, National Academy for Social Prescribing.
社会处方在英国和世界各地都在迅速增长。然而,目前尚不清楚它的目标是谁,以及它的执行效果如何。本研究旨在评估英国初级保健系统中社会处方的纵向趋势,包括增长轨迹和目标一致性,转诊患者的社会人口学概况,以及随着时间的推移拒绝服务的预测因素。方法:这项全国性的纵向观察性研究分析了英国临床实践研究数据链中来自1736名全科医生(GP)实践的120万名患者的初级保健记录。我们在实践层面使用社会处方数量的增长曲线模型估计了2019年至2023年的社会处方趋势。描述性分析用于显示社会处方患者的社会人口学特征随时间的变化。为了评估拒绝服务的社会人口差异(定义为有社会处方下降的医疗代码),我们使用了按年分层的多层次逻辑回归模型,考虑了嵌套的数据结构,其中患者嵌套在实践中。研究结果显示,截至2023年底,英格兰估计有940万次全科医生咨询涉及社会处方代码,550万次咨询专门涉及社会处方转诊。仅在2023年,估计就有130万患者转诊到社会处方。提供社会处方的患者中,女性占60%,少数民族占23%。2017年至2023年间,生活在更贫困地区的患者比例从23%增加到42%。2019年至2023年间,服务拒绝率从22%下降到12%。年龄、性别和种族与多年拒绝服务有关。值得注意的是,在2023年,与最年轻的年龄组相比,所有年龄组的拒绝率都更高。女性患者的拒绝率比男性低21% (95% CI 0.77 ~ 0.82),白人患者的拒绝率比少数民族患者高32%(1.26 ~ 1.39)。社会处方在英格兰迅速扩张,到2023-24年远远超过最初的目标90万患者,这表明广泛的服务可接受性。在接触特定目标群体,例如较为贫困的社区方面正在取得进展。然而,在可及性和吸收方面仍然存在差距,需要制定有针对性的战略来解决潜在的不平等现象。资金mq转变心理健康,rosetree - stoneygate信托奖学金,国家社会处方学会。
{"title":"National roll-out of social prescribing in England's primary care system: a longitudinal observational study using Clinical Practice Research Datalink data","authors":"Feifei Bu, Alexandra Burton, Naomi Launders, Amy E Taylor, Alvin Richards-Belle, Stephanie Tierney, David Osborn, Daisy Fancourt","doi":"10.1016/s2468-2667(25)00217-8","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00217-8","url":null,"abstract":"<h3>Background</h3>Social prescribing is growing rapidly in England and across the world. However, it remains unclear who it is reaching and how effectively it is being implemented. This study aimed to assess longitudinal trends in social prescribing in England's primary care system, including growth trajectories and target alignment, sociodemographic profiles of referred patients, and predictors of service refusal over time.<h3>Methods</h3>This nationwide, longitudinal observational study analysed primary care records from 1·2 million patients from 1736 general practitioner (GP) practices in the Clinical Practice Research Datalink in England. We estimated social prescribing trends between 2019 and 2023 using growth curve modelling on social prescribing numbers at the practice level. Descriptive analyses were used to show changes in sociodemographic profiles of social prescribing patients over time. To assess sociodemographic disparities in service refusal (defined as having a medical code of social prescribing declined), we used multilevel logistic regression models stratified by year, accounting for nested data structure where patients were nested within practices.<h3>Findings</h3>As of the end of 2023, an estimated 9·4 million GP consultations in England have involved social prescribing codes, and 5·5 million consultations have specifically led to social prescribing referrals. In 2023 alone, an estimated 1·3 million patients were referred to social prescribing. 60% of patients offered social prescribing were female and 23% were from ethnic minority groups. Representation from patients living in more deprived areas increased from 23% to 42% between 2017 and 2023. Service refusal declined from 22% to 12% between 2019 and 2023. Age, sex, and ethnicity were associated with service refusal across multiple years. Notably, in 2023, all age groups had higher odds of refusal compared with the youngest age group. Female patients had 21% (95% CI 0·77–0·82) lower odds of refusal than males, and patients from White ethnic backgrounds had 32% (1·26–1·39) higher odds of refusal than ethnic minority patients.<h3>Interpretation</h3>Social prescribing has expanded rapidly in England, far exceeding initial targets of 900 000 patients by 2023–24, suggesting broad service acceptability. Progress is being made in reaching specific target groups, such as more deprived communities. However, there are still disparities in accessibility and uptake, calling for targeted strategies to address underlying inequalities.<h3>Funding</h3>MQ Transforming Mental Health, Rosetrees-Stoneygate Trust Fellowship, National Academy for Social Prescribing.","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"21 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145153669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is a Wellbeing Economy, and what might its impact be on population health? 什么是福利经济?福利经济对人口健康有何影响?
IF 5 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2025-09-22 DOI: 10.1016/s2468-2667(25)00192-6
Gerry McCartney, Milena Büchs, Martin Hensher, Micaela Mazzei
The current polycrisis (intersecting and mutually-reinforcing crises that are impacting our ecological, social, and economic systems) has foregrounded the need to transform economies to put them in service of people and planet, rather than design them in pursuit of ever more economic growth. This approach, termed a Wellbeing Economy, is the subject of considerable policy interest and could have substantial impacts on population health if widely implemented. We discuss different interpretations of similar terms for economic systems and how these interpretations imply incremental reforms to the dominant capitalist model, or a radical break in economic design. We detail routes to a Wellbeing Economy and suggest that more radical approaches hold greater potential to address the polycrisis and protect population health. We summarise how the implementation of a Wellbeing Economy could be a commensurate response to the polycrisis that might also yield substantial benefits for population health.
当前的多重危机(影响我们的生态、社会和经济系统的相互交叉和相互加强的危机)凸显了改革经济的必要性,使其为人类和地球服务,而不是为了追求更多的经济增长而设计经济。这一方法被称为福利经济,是引起相当大政策关注的主题,如果得到广泛实施,可能对人口健康产生重大影响。我们讨论了对经济系统类似术语的不同解释,以及这些解释如何意味着对占主导地位的资本主义模式的渐进改革,或者经济设计的根本突破。我们详细介绍了通往幸福经济的路线,并建议更激进的方法在解决多重危机和保护人口健康方面具有更大的潜力。我们总结了福利经济的实施如何成为对多重危机的相称反应,这也可能为人口健康带来实质性利益。
{"title":"What is a Wellbeing Economy, and what might its impact be on population health?","authors":"Gerry McCartney, Milena Büchs, Martin Hensher, Micaela Mazzei","doi":"10.1016/s2468-2667(25)00192-6","DOIUrl":"https://doi.org/10.1016/s2468-2667(25)00192-6","url":null,"abstract":"The current polycrisis (intersecting and mutually-reinforcing crises that are impacting our ecological, social, and economic systems) has foregrounded the need to transform economies to put them in service of people and planet, rather than design them in pursuit of ever more economic growth. This approach, termed a Wellbeing Economy, is the subject of considerable policy interest and could have substantial impacts on population health if widely implemented. We discuss different interpretations of similar terms for economic systems and how these interpretations imply incremental reforms to the dominant capitalist model, or a radical break in economic design. We detail routes to a Wellbeing Economy and suggest that more radical approaches hold greater potential to address the polycrisis and protect population health. We summarise how the implementation of a Wellbeing Economy could be a commensurate response to the polycrisis that might also yield substantial benefits for population health.","PeriodicalId":56027,"journal":{"name":"Lancet Public Health","volume":"9 1","pages":""},"PeriodicalIF":50.0,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145116391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Lancet Public Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1